Inovio Pharmaceuticals (INO) Non-Current Debt (2019)
Inovio Pharmaceuticals (INO) posted Non-Current Debt of $62.8 million for Q2 2019, up 3.62% sequentially from $60.6 million in Q1 2019.
Inovio Pharmaceuticals (INO) Non-Current Debt (2019) Analysis & Trends
Inovio Pharmaceuticals has reported Non-Current Debt for 1 years, with the latest figure at $62.8 million in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.65 Bn | 130.80 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.93 Bn | 77.94 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.84 Bn | 59.66 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.38 Bn | 52.25 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.94 Bn | 36.84 Bn | 1.53 Bn | 882.16 Mn |
| 6 | Alnylam Pharmaceuticals | 31.54 Bn | 28.23 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.72 Bn | 9.33 Bn | 668.28 Mn | 360.97 Mn |
| 8 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 8.96 Bn |
| 10 | Inovio Pharmaceuticals | 95.27 Mn | 95.27 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 62.76 Mn |
| Mar 31, 2019 | 60.56 Mn |